CAN VITAMIN D PROTECT AGAINST CANCER?

 

CAN VITAMIN D PROTECT AGAINST CANCER?









According to a new research review, a good vitamin D status is beneficial both in cancer prevention and in the prognosis of several cancers. The anti-cancer effects of vitamin D are especially pronounced in preventing and treating colon cancer and blood cancers. Also, high vitamin D responsiveness can be linked to smaller cancer risk. Vitamin D responsiveness varies between individuals, affecting their need for vitamin D supplementation.

The review article, published in Seminars in Cancer Biology and written by Professor Carsten Carlberg from the University of Eastern Finland and Professor Alberto Muñoz from the Autonomous University of Madrid, provides an updated molecular basis of vitamin D signaling and its role in cancer prevention and therapy.

Vitamin D is commonly known for its crucial role in bone health. Still, the authors point out it also regulates the immune system, and its anti-cancer effects are mediated mainly by immune cells, such as monocytes and T cells. Vitamin D exerts its effects via the vitamin D receptor (VDR), a transcription factor involved in the expression and epigenetic regulation of numerous genes.

According to the review, studies focusing on vitamin D's effect on different types of cancers provide the strongest evidence of its benefits in colorectal cancer and in blood cancers, such as leukemias and lymphomas. Vitamin D is important both for the differentiation of blood cells during hematopoiesis and adult stem cells in rapidly regenerating tissues, such as the colon or skin. A too-low vitamin D status leads to a suboptimal function of the VDR and in an increased risk that these cells are not fully differentiating and start to turn into uncontrolled growing cancer cells.

Even in other types of cancer, such as breast and prostate cancer, a low vitamin D status, measured as the level of 25-hydroxyvitamin D in the blood, has been associated with a higher cancer incidence and a poorer prognosis. However, vitamin D supplementation has not been consistently shown to reduce cancer mortality in randomized controlled trials. According to the authors of the review, vitamin D's impact could be shown more clearly if the participants were stratified according to their individual vitamin D responsiveness and the health outcomes analyzed about changes in individual vitamin D status.

Professor Carlberg's research group has shown that individuals differ in their molecular response or sensitivity to vitamin D supplementation. For example, 25% of the Finnish population seem to be low responders, needing a higher vitamin D supplementation to reach the full clinical benefit. In terms of cancer risk, being a high responder can be expected to have a protective effect.

According to the review, a good vitamin D status is beneficial in general cancer prevention. There is less evidence of its usefulness in the treatment of cancer.


Comments

Popular posts from this blog

B12 MAY HELP PREVENT ALZHEIMER'S DISEASE.

EXTREME HEAT MAY NEGATIVELY IMPACT COGNITIVE HEALTH

Diabetes drugs may reduce the risk of Alzheimer’s.